ShortCut device study for heart valve replacement
Part of Heart & circulation clinical trials.
This study tests a new device called ShortCut to help doctors safely replace a failing bioprosthetic heart valve (a valve that was placed in your heart previously) using a minimally invasive procedure. The ShortCut is designed to protect your coronary arteries—the vessels that supply blood to your heart—during this valve replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 22 years old
- Your doctor has recommended a valve-in-valve TAVR procedure (a catheter-based valve replacement) using the ShortCut device
- Your heart imaging shows you are at risk for coronary artery blockage during the procedure
- You have no medical conditions that make the ShortCut unsafe for you
- Your heart valve calcium buildup and anatomy are suitable for this device, confirmed by CT scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new filter device designed to catch debris that might travel to the brain during a minimally invasive aortic valve replacement (TAVR). The goal is to see if it can help reduce the risk of stroke.
This trial tests a minimally invasive procedure called TAVI (transcatheter aortic valve implantation) to replace a narrowed aortic valve without requiring open-heart surgery. The study is checking whether TAVI can be safely performed at hospitals that don't have cardiac surgery units on-site.
This study uses a CT scan plus a personalized computer model to plan a less invasive valve replacement (TAVR). It may help doctors better prepare for the procedure using simulation before your valve is placed.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This trial tests if a heart valve replacement procedure called TAVI can be safely done at heart centers that do not have a full heart surgery team available onsite. It is for people with severe narrowing of the aortic valve who are already planned for TAVI through the leg artery.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
Hear when a new Aortic Stenosis Treated With TAVI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.